Multiple heterogeneous cell surface receptors and signaling pathways

Multiple heterogeneous cell surface receptors and signaling pathways is a broad descriptor for a variety of membrane proteins and their downstream effects, rather than a single, well-defined therapeutic target. Cell surface receptors, such as G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs), are essential for sensing extracellular signals and initiating intracellular responses (Alberts et al., Molecular Biology of the Cell, 6th ed.). These receptors activate complex signaling networks, including the PI3K/Akt and MAPK/ERK pathways, which govern fundamental processes like cell proliferation, survival, and metabolism (Seshacharyulu et al., 2012, Expert Opin Ther Targets). Because this term encompasses a vast array of functionally and structurally distinct molecules, it lacks the specificity required for drug-target interaction analysis. In drug discovery, specific receptors or enzymes within these pathways are targeted to treat conditions like cancer, but the collective term itself does not represent a valid pharmacological target. Dysregulation of these pathways is a hallmark of many diseases, yet therapeutic strategies must focus on individual components to be effective. Consequently, this entry is classified as incorrect for the purposes of specific target identification.

Not applicable as this refers to a broad category of targets rather than a single molecule.